SCHEMBL10041275

SCHEMBL10041275

CC(C)(C)c1nc2ccccc2n1-c1cc(-n2c(C(C)(C)C)nc3ccccc32)cc([Si](c2ccccc2)(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.42
HTT P42858 1/20 0.42
SLC22A12 Q96S37 3/20 0.39
CNR2 P34972 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
ADORA2A P29274 1/20 0.34
POLB P06746 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ALDH1A1 P00352 3/20 0.34
KDM4E B2RXH2 2/20 0.34
HPGD P15428 2/20 0.34
GAA P10253 2/20 0.34
LMNA P02545 2/20 0.34
TSHR P16473 1/20 0.34
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
MAPT P10636 1/20 0.34
GSR P00390 2/20 0.33
ALOX15 P16050 1/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10041258 0.82 MAPK1 (0.49) MAPK1HTTSLC22A12CNR2SMN1; SMN2
SCHEMBL12026134 0.82 MAPK1 (0.61) MAPK1HTTSLC22A12CNR2SMN1; SMN2
SCHEMBL10041274 0.81 MAPK1 (0.43) MAPK1HTTSLC22A12CNR2SMN1; SMN2
SCHEMBL10041276 0.79 GSR (0.52) MAPK1HTTSMN1; SMN2ADORA2AALDH1A1
SCHEMBL63683 0.78 SLC22A12 (0.46) MAPK1HTTSLC22A12CNR2SMN1; SMN2
SCHEMBL20286689 0.77 MAPK1 (0.50) MAPK1HTTSLC22A12CNR2SMN1; SMN2
SCHEMBL25878198 0.76 MAPK1 (0.46) MAPK1HTTSLC22A12CNR2SMN1; SMN2
SCHEMBL10041284 0.76 MAPK1 (0.53) MAPK1HTTSLC22A12CNR2ALDH1A1
SCHEMBL13425056 0.76 ALDH1A1 (0.38) MAPK1HTTALDH1A1KDM4EHPGD
SCHEMBL23251179 0.75 CNR2 (0.42) MAPK1HTTSLC22A12CNR2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8147987-B2 Organic electroluminescent element and compounds for use in the element FUJIFILM CORPORATION (JP) 2012-04-03 US disclosed
US-20070202357-A1 Organic electroluminescent element and compounds for use in the element FUJIFILM CORPORATION (JP) 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070202357-A1 Organic electroluminescent element and compounds for use in the element RPL31, RPL38, RPL39 MAPK1 1465/4885HTT 3850/4885SLC22A12 871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.